Results for tag: "Hydrea"

Hydrea is a chemotherapy drug used to treat chronic myeloid leukemia (CML). It is a hydroxyurea-based medication that works by inhibiting the production of cancer cells. It is also used to treat other types of leukemia, such as acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Hydrea is typically used in combination with other drugs, such as interferon or imatinib, to increase its effectiveness. It is also used to reduce the risk of blood clots in patients with CML. Hydrea is available in both oral and intravenous forms. It is generally well-tolerated, but can cause side effects such as nausea, vomiting, and diarrhea. It can also cause anemia, low white blood cell count, and low platelet count. The Hydrea market is highly competitive, with several companies offering similar products. Some of the major players in the market include Novartis, Bristol-Myers Squibb, Pfizer, and Merck. Other companies include GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more